Insmed INSM
NASDAQ INSM
$108.59 -5.55 (-4.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Insmed (INSM) Cash from Financing Activities (2010 - 2026)

Updated

Insmed (INSM) recorded Cash from Financing Activities of $27.18 million in Q2 2026, down 96.8% from $857.81 million a year earlier and down 7.9% from the prior quarter.

Analysis

Insmed (INSM) Cash from Financing Activities (2010 - 2026) Analysis & Trends

On a TTM basis, Insmed's Cash from Financing Activities came in at $123.96 million as of Jun 30, 2026, down 91.4% year-over-year; for FY2025, it came in at $954.07 million, down 28.9% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of 28.6% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $1.34 billion in FY2024 (+696.1%), $168.44 million in FY2023 (-78.8%), $793.27 million in FY2022 (+29.5%) and $612.55 million in FY2021 (+126.0%).
  • The Q2 2026 figure is the lowest quarterly Cash from Financing Activities since Q1 2024.
  • On a year-over-year basis, Cash from Financing Activities rose in four of the last seven quarters, with growth averaging 90.5%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 859.6% in Q1 2025, against a decline of 98.9% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $29.51 million (Q1 2026), $33.86 million (Q4 2025) and $33.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Insmed 24.91 Bn 19.42 Bn 358.27 Mn 27.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.18 Mn
Mar 31, 2026 29.51 Mn
Dec 31, 2025 33.86 Mn
Sep 30, 2025 33.41 Mn
Jun 30, 2025 857.81 Mn
Mar 31, 2025 29.00 Mn
Dec 31, 2024 159.31 Mn
Sep 30, 2024 397.20 Mn
Jun 30, 2024 781.49 Mn
Mar 31, 2024 3.02 Mn
Dec 31, 2023 123.26 Mn
Sep 30, 2023 1.25 Mn
Jun 30, 2023 44.33 Mn
Mar 31, 2023 -399,000.00
Dec 31, 2022 743.39 Mn
Sep 30, 2022 37.12 Mn
Jun 30, 2022 6.31 Mn
Mar 31, 2022 6.46 Mn
Dec 31, 2021 5.71 Mn
Sep 30, 2021 2.54 Mn
API Access

Insmed Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INSM&period=max&api_key=YOUR_API_KEY